Galecto Biotech

Galecto Biotech AB is a seed stage company founded by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark. The company builds on more than 10 years of research into galectins and galectin modulators, which combined with a strong patent estate gives Galecto Biotech a unique platform. The company develops galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Galecto is based in Copenhagen, Denmark.

http://www.galecto.com

Team Member
more about
Jasper Bos
all portfolio news